The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications.
Articolo
Data di Pubblicazione:
2011
Citazione:
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications / Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - 155:(2011), pp. 438-448. [10.1111/j.1365-2141.2011.08864.x]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Podar, K; Zimmerhackl, A; Fulciniti, M; Tonon, G; Hainz, U; Tai, Yt; Vallet, S; Halama, N; Jäger, D; Olson, Dl; Sattler, M; Chauhan, D; Anderson, Kc.
Link alla scheda completa:
Pubblicato in: